B6-huIL15 Mouse
제품명
B6-huIL15 Mouse
제품 ID
C001853
품종 계통
C57BL/6NCya-Il15tm1(hIL15)/Cya
Backgroud
C57BL/6NCya
상태
이 마우스 계통을 논문에서 사용할 경우, “B6-huIL15 Mouse (카탈로그 번호 C001853)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
유전자명
유전자 별칭
IL-15
NCBI ID
염색체
Chr 4
MGI ID
Datasheet
품종 계통 설명
The IL15 gene encodes a pleiotropic four-α-helix bundle cytokine known as Interleukin-15 (IL-15), which is essential for the development, survival, and activation of immune cells, particularly Natural Killer (NK) cells and memory CD8+ T cells. Unlike many cytokines, IL-15 is primarily regulated at the post-transcriptional and translational levels rather than just transcriptionally, and it is uniquely delivered to target cells through trans-presentation, where it is shuttled to the cell surface bound to its high-affinity receptor, IL-15Rα [1]. The protein is widely expressed across a variety of tissues, including the placenta, skeletal muscle, kidney, lung, and heart, and is produced by both hematopoietic cells (such as monocytes, macrophages, and dendritic cells) and non-hematopoietic cells (such as epithelial cells and fibroblasts) [2]. Functionally, IL-15 triggers the JAK/STAT (specifically JAK1/3 and STAT3/5) and PI3K/AKT/mTOR signaling pathways to promote cellular proliferation and inhibit apoptosis by upregulating anti-apoptotic factors like BCL2 [3]. Because of its potent inflammatory effects, dysregulation of the IL15 gene is implicated in several pathologies: over-expression is strongly associated with autoimmune diseases like Celiac disease, Rheumatoid Arthritis, and Multiple Sclerosis, as well as certain malignancies like Adult T-cell Leukemia, while its deficiency can lead to severe immunodeficiency or impaired response to viral infections [4].
The B6-huIL15 mouse is a humanized model constructed through gene-editing technology, in which the region from partial intron 4 to TGA stop codon of mouse Il15 is replaced with the region from partial intron 4 to TGA stop codon of human IL15. This model can be used for research on autoimmune diseases like Celiac disease, Rheumatoid Arthritis, and Multiple Sclerosis, as well as certain malignancies like Adult T-cell Leukemia. Furthermore, it serves as a platform for the screening, development, and preclinical evaluation of IL15-targeted therapeutics.
Reference
Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001 Jan 1;97(1):14-32.
Perera PY, Lichy JH, Waldmann TA, Perera LP. The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect. 2012 Mar;14(3):247-61.
Mishra A, Sullivan L, Caligiuri MA. Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res. 2014 Apr 15;20(8):2044-50.
Meghnem D, Maillasson M, Barbieux I, Morisseau S, Keita D, Jacques Y, Quéméner A, Mortier E. Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation. Front Immunol. 2022 May 3;13:886213.
변형 전략
The region from partial intron 4 to TGA stop codon of mouse Il15 was replaced with the region from partial intron 4 to TGA stop codon of human IL15.
Figure 1. Diagram of the gene editing strategy for the generation of B6-huIL15 mice.
응용 분야
Screening, development and pre-clinical evaluation of IL15-targeted drugs;
Research on autoimmune diseases, such as celiac disease, rheumatoid arthritis, and multiple sclerosis;
Research on the pathogenic mechanisms and related treatment methods of malignant tumors, such as adult T-cell leukemia.
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.